Eur Rev Med Pharmacol Sci 2023; 27 (6): 2469-2476
DOI: 10.26355/eurrev_202303_31780

Association of cardiometabolic risks with body composition in hemodialysis patients

N. Arslan

Nutrition and Dietetic Department, Ataturk Faculty of Health Sciences, Dicle University, Diyarbakır, Turkey. nuracar_1986@hotmail.com


OBJECTIVE: High body fat ratio is known as one of the main reasons that increase the risk of cardiovascular disease. This study examined the relationship between body composition and cardiometabolic risks in hemodialysis (HD) patients.

PATIENTS AND METHODS: This study was conducted with chronic kidney disease (CKD) patients who received HD treatment between March 2020 and September 2021. Anthropometric measurements of the individuals and their body composition analyses were performed using the bioelectrical impedance analysis (BIA) method. Framingham risk scores were calculated in order to determine the cardiometabolic risk factors of individuals.

RESULTS: According to the Framingham risk score, 15.96% of individuals were found to have a high cardiometabolic risk. The lean-fat tissue index (LTI)/(FTI), body shape index (BSI) and visceral adiposity index (VAI) (female-male) values of individuals with high risk according to the Framingham risk score were found to be 11.34±2.29, 13.52±2.88, 8.50±3.89, 9.60±3.07, 0.086±0.024, respectively. The effect of anthropometric measurements in estimating the Framingham risk score was examined using the linear regression analysis. The regression analysis performed with BMI, LTI, VAI values, it was determined that 1-unit increase in VAI increased the Framingham risk score by 1,468 units (OR: 0.951-1.952) (p=0.002).

CONCLUSIONS: It has been discovered that indices indicating adipose tissue increase the Framingham risk score in HD patients, independent of BMI. It is recommended to evaluate the ratios showing body fat ratio in cardiovascular diseases.

Free PDF Download

To cite this article

N. Arslan
Association of cardiometabolic risks with body composition in hemodialysis patients

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 6
Pages: 2469-2476
DOI: 10.26355/eurrev_202303_31780